Summary
To investigate tumor angiogenesis in benign, borderline and malignant epithelial ovarian tumors and its relation with the pathogenesis of ovarian carcinoma, polycolonal antibody directed against human von Willebrand factor (factor VIII) was used to measure the microvessel density (MVD) in 66 cases (11 benign, 10 borderline, and 45 malignant) of epithelial ovarian tumors by using immunohistochemistry. The results showed that the mean MVD in epithelial ovarian cancer (31.7±11.2, 400X) was higher than in benign and borderline tumors (16.7±6.3, 20.7±8.8 respectively,P<0.05). There was no difference in MVDs among those in different tumor grades (P>0.05). But there was significant difference in MVDs among those in different tumor stages (P<0.05). MVD in stage III –IV cancer was higher than that in stage I–II (P<0.05). It is concluded that the tumor angiogenesis is an early event in ovarian tumorgenesis. The increased tumor micovessel might be responsible for tumor development.
Similar content being viewed by others
References
Orre M, Lotfi-Miri M, Mamers Pet al. Increased microvessel density in mucinous compared with malignant serous and benign tumors of the ovary. Br J Cancer, 1998, 77:2204
Hollingsworth H C, Kihn E C, Steinberg S Met al. Tumor angiogenesis in advanced stage ovarian carcinomas. Am J Pathol 1995, 147:33
Hermann B, Paul R, Susanna Net al. The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: A quantitative histologic study. Gynecol Oncol, 1997, 67:20
Gasparini G, Bonoldi E, Viale Get al. Prognostic and predictive value of tumor Angiogenesis in ovarian carcinomas. Int J Cancer, 1996, 69:205
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zehua, W., Hongbo, W. & Meihua, L. Study on tumor angiogenesis in epithelial ovarian carcinoma. Current Medical Science 20, 172–174 (2000). https://doi.org/10.1007/BF02887065
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02887065